Maverick Capital Ltd holds a diversified book of 239 stocks worth $8.6B as of Q1 2026 (disclosed May 15, 2026, a ~45-day 13F lag). This quarter they opened Linde PLC and trimmed Amazon.com Inc. Their largest long position is Nvidia Corp at 6% of the equity book. They also disclosed $71.1M in call options (bullish), shown separately below and excluded from the equity book.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/934639/holdings"
Use Arkolith to show MAVERICK CAPITAL LTD's latest holdings, largest changes, and filing provenance.
Top-heavy: diversified book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
100% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Nvidia Corporation COM | $553.7M | 3.17M | 6.4% | ▲+6.3% Added · +189K sh | |
| 2 | Amazon Com Inc COM | $482.8M | 2.32M | 5.6% | ▼−2.7% Reduced · −65K sh | |
| 3 | Taiwan Semiconductor Manufac SPONSORED ADS | $418.2M | 1.24M | 4.9% | ▼−25% Reduced · −421K sh | |
| 4 | ASML Hldg NV N Y REGISTRY SHS | $341.3M | 258.4K | 4.0% | ▼−1.0% Reduced · −3K sh | |
| 5 | Nu Hldgs Ltd ORD SHS CL A | $322.5M | 22.44M | 3.8% | ▲+92% Added · +10.7M sh | |
| 6 | Applied Matls Inc COM | $297.3M | 869.9K | 3.5% | ▼−23% Reduced · −261K sh | |
| 7 | Microsoft Corp COM | $268.6M | 725.6K | 3.1% | ▼−37% Reduced · −425K sh | |
| 8 | RTX Corporation COM | $263.3M | 1.36M | 3.1% | ▼−0.3% Reduced · −4K sh | |
| 9 | Boston Scientific Corp COM | $263.2M | 4.20M | 3.1% | ▲+42% Added · +1.3M sh | |
| 10 | Argan Inc COM | $253.1M | 464.8K | 2.9% | ▲+5.9% Added · +26K sh | |
| 11 | Alphabet Inc CAP STK CL C | $250.3M | 872.7K | 2.9% | ▼−24% Reduced · −269K sh | |
| 12 | Bio-Techne Corp COM | $247.7M | 4.74M | 2.9% | ▲+23% Added · +889K sh | |
| 13 | Visa Inc COM CL A | $243.9M | 807.0K | 2.8% | ▲+3.9% Added · +30K sh | |
| 14 | Natera Inc COM | $234.3M | 1.17M | 2.7% | ▲+24% Added · +228K sh | |
| 15 | Capital One Finl Corp COM | $227.8M | 1.25M | 2.6% | ▼−3.7% Reduced · −48K sh | |
| 16 | Linde PLC SHS | $211.2M | 426.1K | 2.5% | ▲New New position | |
| 17 | Dicks Sporting Goods Inc COM | $207.2M | 1.04M | 2.4% | ▲+25% Added · +211K sh | |
| 18 | Infleqtion Inc COM SHS | $195.6M | 19.94M | 2.3% | ▲New New position | |
| 19 | Southwest Gas Hldgs Inc COM | $184.8M | 2.13M | 2.1% | ▲+3.9% Added · +79K sh | |
| 20 | Camden Ppty TR SH BEN INT | $182.4M | 1.87M | 2.1% | ▲+1.6% Added · +30K sh | |
| 21 | Abbott Laboratories COM | $180.5M | 1.76M | 2.1% | ▲New New position | |
| 22 | Repligen Corp COM | $178.9M | 1.52M | 2.1% | ▲New New position | |
| 23 | Monster Beverage Corp New COM | $178.6M | 2.46M | 2.1% | ▼−8.5% Reduced · −228K sh | |
| 24 | GFL Environmental Inc SUB VTG SHS | $160.6M | 3.85M | 1.9% | ▼−23% Reduced · −1.2M sh | |
| 25 | Danaher Corp Del COM | $155.4M | 819.7K | 1.8% | ▲New New position | |
| 26 | Advanced Micro Devices Inc COM | $137.6M | 676.6K | 1.6% | ▲New New position | |
| 27 | Intel Corp COM | $132.2M | 3.00M | 1.5% | ▲New New position | |
| 28 | Carvana Co CL A | $132.1M | 420.3K | 1.5% | ▼−9.0% Reduced · −42K sh | |
| 29 | Sherwin Williams Co COM | $125.6M | 391.8K | 1.5% | ▲+38% Added · +108K sh | |
| 30 | Astera Labs Inc COM | $104.7M | 955.4K | 1.2% | ▼−2.1% Reduced · −21K sh | |
| 31 | Coca Cola Co COM | $97.7M | 1.28M | 1.1% | ▼−18% Reduced · −278K sh | |
| 32 | Philip Morris Intl Inc COM | $93.8M | 567.3K | 1.1% | ▼−74% Reduced · −1.6M sh | |
| 33 | McDonalds Corp COM | $91.4M | 294.1K | 1.1% | ▲24× Added · +282K sh | |
| 34 | Molina Healthcare Inc COM | $86.1M | 645.8K | 1.0% | ▲New New position | |
| 35 | Vaxcyte Inc COM | $80.1M | 1.38M | 0.9% | ▲+1.7% Added · +24K sh | |
| 36 | Novo-Nordisk A S ADR | $76.4M | 2.08M | 0.9% | ▲New New position | |
| 37 | Wave Life Sciences Ltd SHS | $73.7M | 10.16M | 0.9% | ▲+9.5% Added · +881K sh | |
| 38 | Centessa Pharmaceuticals PLC SPONSORED ADS | $73.7M | 1.85M | 0.9% | ▲+13% Added · +211K sh | |
| 39 | Newamsterdam Pharma Company ORDINARY SHARES | $70.0M | 2.19M | 0.8% | ▲+15% Added · +292K sh | |
| 40 | Fluor Corp COM | $66.0M | 1.42M | 0.8% | ▲New New position | |
| 41 | Corning Inc COM | $50.9M | 374.5K | 0.6% | ▲New New position | |
| 42 | Mirion Technologies Inc COM CL A | $49.3M | 2.65M | 0.6% | ▲New New position | |
| 43 | Merit Med Sys Inc COM | $49.2M | 714.1K | 0.6% | ▲+47% Added · +228K sh | |
| 44 | Mercadolibre Inc COM | $46.5M | 26.9K | 0.5% | ▲+2.8% Added · +745 sh | |
| 45 | Roivant Sciences Ltd SHS | $45.1M | 1.63M | 0.5% | ▲New New position | |
| 46 | Compass Inc CL A | $37.8M | 5.17M | 0.4% | ▼−59% Reduced · −7.5M sh | |
| 47 | Medline Inc COM CL A | $35.4M | 796.1K | 0.4% | —Held | |
| 48 | Acadia Healthcare Company In COM | $30.7M | 1.31M | 0.4% | ▲+45% Added · +409K sh | |
| 49 | Invivyd Inc COM | $24.7M | 18.97M | 0.3% | —Held | |
| 50 | Marvell Technology Inc COM | $18.6M | 188.2K | 0.2% | ▲New New position |
Put / call positions from the 13F — totals include every disclosed option leg
| Type | Underlying | Notional value | Underlying shares |
|---|---|---|---|
| CALL · bullish | BOSTON SCIENTIFIC CORPBSX | $62.8M | 1.0M |
| CALL · bullish | WAVE LIFE SCIENCES LTDWVE | $8.4M | 1.2M |
13F filers disclose option positions at the market value of the underlying the contracts reference, not the premium paid. A put is a bearish bet (it gains if the stock falls); a call is bullish. “Underlying shares” is the share count the contracts control, not a share holding. These legs are excluded from the equity book, weighting, concentration and sector figures above.
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q1 2026 | Mar 31, 2026 | May 15, 2026 | 241 | $8.7B | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 13, 2026 | 179 | $9.3B | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Nov 14, 2025 | 203 | $7.5B | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Aug 14, 2025 | 251 | $6.7B | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 15, 2025 | 235 | $5.7B | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Feb 14, 2025 | 225 | $5.6B | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Nov 14, 2024 | 229 | $5.1B | 13F-HR |
| Q2 2024 | Jun 30, 2024 | Aug 14, 2024 | 267 | $5.3B | 13F-HR |
| Q1 2024 | Mar 31, 2024 | May 15, 2024 | 405 | $5.3B | 13F-HR |
| Q4 2023 | Dec 31, 2023 | Feb 14, 2024 | 348 | $5.0B | 13F-HR |
| Q3 2023 | Sep 30, 2023 | Nov 14, 2023 | 301 | $4.4B | 13F-HR |
| Q2 2023 | Jun 30, 2023 | Aug 14, 2023 | 392 | $4.7B | 13F-HR |
| Q1 2023 | Mar 31, 2023 | May 15, 2023 | 449 | $4.0B | 13F-HR |
| Q4 2022 | Dec 31, 2022 | Feb 16, 2023 | 377 | $4.2B | 13F-HR/A |
| Q3 2022 | Sep 30, 2022 | Nov 14, 2022 | 344 | $4.4B | 13F-HR |
| Q2 2022 | Jun 30, 2022 | Aug 15, 2022 | 212 | $4.1B | 13F-HR |
| Q1 2022 | Mar 31, 2022 | May 16, 2022 | 227 | $5.7B | 13F-HR/A |
| Q4 2021 | Dec 31, 2021 | Feb 14, 2022 | 308 | $8.8B | 13F-HR |
| Q3 2021 | Sep 30, 2021 | Nov 15, 2021 | 625 | $9.9B | 13F-HR |
| Q2 2021 | Jun 30, 2021 | Aug 18, 2021 | 661 | $10.6B | 13F-HR/A |
| Q1 2021 | Mar 31, 2021 | May 17, 2021 | 688 | $10.9B | 13F-HR |
Managing Partner of Maverick Capital.
Holdings from SEC EDGAR 13F-HR filings, updated quarterly ~45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.